Growth Fundamentals
The market potential is of 175 - 1050 million USD/year.
The Phase III trials will be restarted 2008, the market introduction is foreseen for:
Canada - in 2012, Q3
USA - in 2012, Q2Europe - in 2013, Q2
 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
|
||||
 |
 |
 |
 |
 |
|
||||
 |
|
||||||||
|
Growth Fundamentals The market potential is of 175 - 1050 million USD/year. The Phase III trials will be restarted 2008, the market introduction is foreseen for:
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||